Projects funded by the NCN
Potential neuroprotective properties of modulators of sphingosine-1-phosphate (S1P) receptors (fingolimod and siponimod) in toxicity of amyloid beta oligomers: The significance of S1P receptors in Alzheimer's disease
2021/41/N/NZ5/02036
Keywords:
Alzheimer's disease amyloid beta oligomers sphingosine-1-phosphate (S1P) S1P receptors fingolimod siponimod
Descriptors:
- NZ5_7: Human disease treatment
- NZ5_3: Pathogenesis of human diseases
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego Polskiej Akademii Nauk
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM 20 - announced on 2021-03-15
Amount awarded: 140 000 PLN
Project start date (Y-m-d): 2022-01-21
Project end date (Y-m-d): 2024-01-20
Project duration:: 24 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.